MSc Cell, Gene and Novel Therapies at UCL London: Fees 2026 Dates & Requirements

UCL London MSc Cell, Gene and Novel Therapies is a 1 year Full Time Master program. This program is offered On Campus. The first year fees for MSc Cell, Gene and Novel Therapies at UCL London is ₹ 60.51 Lakhs (GBP 46700). Earlier in 2024, the MSc Cell, Gene and Novel Therapies Fee was ₹ 48.59 Lakhs (GBP 37500). This shows that the academic fees has increased by ₹ 1192044 (GBP 9200).

For admission to MSc Cell, Gene and Novel Therapies at UCL London, international students need IELTS: 7.0, TOEFL: 4.5, PTE: 76. The Application Deadline for 2026 Intake is 26 June 2026. For more details, check UCL London Admissions 2026

According to Academy Ranking of World Universities, UCL London ranked 2 out of 500 in Global Ranking.

UCL London MSc Cell, Gene and Novel Therapies Total Fees 2026

The tuition fee for MSc Cell, Gene and Novel Therapies at UCL London is GBP 46700 per year (₹ 60.51 Lakhs). Meanwhile, the total cost is GBP 66758/Year (₹ 86.5 Lakhs). This includes the tuition fee and other expenses such as Living Cost, Books & Supplies, Health Insurance, etc.

The tuition fee for MSc Cell, Gene and Novel Therapies at University College London is as follows:

The other expenses for MSc Cell, Gene and Novel Therapies at University College London is as follows:

MSc Cell, Gene and Novel Therapies Tuition Fee Trends at UCL London

UCL London MSc Cell, Gene and Novel Therapies Fees for Indian students is ₹ 60.51 Lakhs (GBP 46700). This academic fee has increased by ₹ 1192044 (GBP 9200) from 2024. Candidates can check the year on year trends in UCL London Fees in the table below.

UCL London MSc Cell, Gene and Novel Therapies Application Deadlines & Important Dates

The key dates for the application process for MSc Cell, Gene and Novel Therapies at UCL London include:

• Application Deadline for 2026 Intake is 26 June 2026

MSc Cell, Gene and Novel Therapies at UCL London Admission 2026

To be eligible for admission to MSc Cell, Gene and Novel Therapies at UCL London, applicants must meet specific academic and language requirements.

Academic Eligibility:

• Students have a minimum of a second-class Bachelor's degree from a UK university or an overseas qualification of an equivalent standard is required followed by at least three year's full-time work experience.
• A GMAT or GRE, or equivalent standardized test set by UCL and the NSD is also required. A minimum GMAT score of 600 is recommended.
• Students whose official language is not English are required to submit IELTS or TOEFL scores. 
•  Knowledge of mathematical methods and introductory probability and statistics is also required.

Indian Students Eligibility:

• Students hold a Bachelor's degree with a minimum overall CGPA of 6.75/10, 5.75/8.0, 5.25/7.0, 3.75/6.0, 3.0/4.0, or 55% where a GPA scale is not used. The overall mark required is dependent on the subject and the ranking of the institution at which the degree

UCL London MSc Cell, Gene and Novel Therapies Application Link

UCL London MSc Cell, Gene and Novel Therapies Application Link; Apply Here

MSc Cell, Gene and Novel Therapies at UCL London Admission Requirements

For admission to MSc Cell, Gene and Novel Therapies, UCL London accepts IELTS, TOEFL, PTE exam. The average scores among admitted students are typically around: 7 in IELTS, 4.5 in TOEFL, 76 in PTE.

• UCL London Courses and Fees 2026
• UCL London Reviews